In a recent government meeting, a prominent neurologist and neuroscientist highlighted the urgent need for continued research into neurodegenerative diseases, particularly Alzheimer's and Parkinson's diseases. With approximately 7 million individuals affected by Alzheimer's and 1.5 million by Parkinson's in the United States, the speaker emphasized that these numbers are likely underreported and are rapidly increasing.

The speaker, who is also the president of the Institute For Neurodegenerative Disorders (IND), underscored the progressive nature of these diseases, stating, \"the clock is ticking\" for patients and their families. He called for efficient research efforts aimed at identifying effective treatments, drawing parallels to the advancements made in cancer therapies over the past two decades.

A key factor in the recent acceleration of research has been advancements in brain imaging technology, which have facilitated the development of new therapies for Alzheimer's disease that have received FDA approval. The speaker expressed strong support for XING Imaging's Khan application, a company focused on enhancing research capabilities in this field. He praised the company's experienced team, noting their previous contributions to imaging tools that have significantly impacted neurodegenerative disease research.

The meeting underscored a collective commitment to advancing understanding and treatment of these debilitating disorders, with hopes that ongoing research will lead to breakthroughs that improve patient outcomes.